Brief: India's Zim Laboratories Dec-Quarter Consol PAT Falls
11/02/2021 11:42
Feb 11 (Reuters) - Zim Laboratories Ltd ZIML.BO :
* INDIA'S ZIM LABORATORIES LTD DEC-QUARTER CONSOL PAT 12.9
MILLION RUPEES VERSUS 15.2 MILLION RUPEES YEAR AGO
* ZIM LABORATORIES LTD DEC-QUARTER CONSOL REVENUE FROM
OPERATIONS
749.1 MILLION RUPEES VERSUS 733.5 MILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSE5GHCq6
Further company coverage: ZIML.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zim Laboratories
See all newsBrief: Zim Laboratories Gets Marketing Authorization For Dabigatran Etexilate Capsules In Italy, Europe
Brief: Zim Laboratories March-Quarter Consol Net Profit 37.4 Mln Rupees
Brief: Zim Laboratories To Consider Fund Raising Via Securities Issuance
Brief: Zim Laboratories Gets Marketing Authorization For Tamsulosin + Dutasteride Capsules In Australia
India's Zim Laboratories up after getting marketing authorization for migraine drug in Australia